Compound Detail
CHEMBL189
MILRINONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL189 |
| Name | MILRINONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PZRHRDRVRGEVNW-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
21
Targets
87
Activities
3
Assay Types
10
PK Parameters
20
Publications
6
Known Names
10
Indications
Molecular Properties
211.2
MW (Da)
1.62
ALogP
3
HBA
1
HBD
69.5
PSA (Ų)
0.78
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1987 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Cardiovascular Diseases Heart Failure Heart Defects, Congenital Hernias, Diaphragmatic, Congenital Hypertension, Pulmonary Muscle Cramp Shock, Septic Subarachnoid Hemorrhage Vasospasm, Intracranial Reperfusion Injury
ATC Classification
C01CE02
milrinone
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
IC50 78 meas. best 7.0
EC50 7 meas. best 6.2
Ki 2 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Homo sapiens CHEMBL372 | IC50 | 7.0 | 5.8775 | 100.0 | 4 |
| Aorta CHEMBL613606 | IC50 | 6.91 | 6.91 | 122.0 | 1 |
| Phosphodiesterase 3 CHEMBL2094125 | Ki | 6.82 | 6.82 | 150.0 | 1 |
| Phosphodiesterase 3 CHEMBL2094125 | IC50 | 6.68 | 5.7944 | 210.0 | 27 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A CHEMBL241 | IC50 | 6.6 | 5.835 | 250.0 | 4 |
| Unchecked CHEMBL612545 | IC50 | 6.57 | 5.571 | 270.0 | 10 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B CHEMBL290 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.2 | 6.2 | 634.0 | 1 |
| Canis familiaris CHEMBL373 | EC50 | 6.16 | 5.98 | 700.0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase CHEMBL1827 | IC50 | 6.13 | 6.13 | 740.0 | 1 |
| Phosphodiesterase 3A CHEMBL3061 | IC50 | 6.07 | 6.07 | 843.0 | 1 |
| Phosphodiesterase 3B CHEMBL5129 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Phosphodiesterase; PDE3 & PDE4 CHEMBL2095153 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 5.33 | 4.995 | 4700.0 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL2366459 | Ki | 5.33 | 5.33 | 4670.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 5.33 | 5.33 | 4700.0 | 1 |
| Blood CHEMBL613416 | IC50 | 5.33 | 5.33 | 4700.0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase CHEMBL3478 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Felis catus CHEMBL612670 | EC50 | 5.19 | 5.15 | 6500.0 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.96 | 4.7875 | 11000.0 | 4 |
| Plasma CHEMBL613652 | IC50 | 4.96 | 4.91 | 11000.0 | 3 |
| Phosphodiesterase 4A CHEMBL3333 | IC50 | 4.89 | 4.89 | 13000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 6.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.2 | mL.min-1.kg-1 | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| F | 92.0 | % | Homo sapiens |
| Fu | 0.035 | - | Homo sapiens |
| Fu | 0.035 | - | Homo sapiens |
| MRT | 0.67 | hr | Homo sapiens |
| T1/2 | 0.8 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine